Endothelial dysfunction syndromes after allogeneic stem cell transplantation
D Vythoulkas, P Tsirigotis, M Griniezaki, I Konstantellos… - Cancers, 2023 - mdpi.com
Simple Summary Hemato-poietic stem cell transplantation is associated with significant
endothelial dysfunction, which may result in severe complications. Endothelial dysfunction …
endothelial dysfunction, which may result in severe complications. Endothelial dysfunction …
The role of complement in HSCT-TMA: basic science to clinical practice
S Meri, D Bunjes, R Cofiell, S Jodele - Advances in Therapy, 2022 - Springer
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-
TMA) is a common complication occurring post-HSCT and is associated with substantial …
TMA) is a common complication occurring post-HSCT and is associated with substantial …
[HTML][HTML] Harmonizing definitions for diagnostic criteria and prognostic assessment of transplantation-associated thrombotic microangiopathy: a report on behalf of the …
ML Schoettler, E Carreras, B Cho, CE Dandoy… - … and cellular therapy, 2023 - Elsevier
Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly
recognized complication of hematopoietic cell transplantation (HCT) associated with …
recognized complication of hematopoietic cell transplantation (HCT) associated with …
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy and the role of advanced practice providers and pharmacists
Z Mahmoudjafari, MC Alencar, MD Alexander… - Bone Marrow …, 2023 - nature.com
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-
TMA) is a severe and potentially life-threatening complication. HSCT-TMA is often …
TMA) is a severe and potentially life-threatening complication. HSCT-TMA is often …
Transplant-associated thrombotic microangiopathy in the context of allogenic hematopoietic stem cell transplantation: where we stand
I Lazana - International Journal of Molecular Sciences, 2023 - mdpi.com
Transplant-associated thrombotic microangiopathy (TA-TMA) constitutes a significant
contributor to the increased morbidity and mortality after allogenic hematopoietic stem cell …
contributor to the increased morbidity and mortality after allogenic hematopoietic stem cell …
Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients
S Jodele, A Sabulski - Expert Review of Hematology, 2021 - Taylor & Francis
Introduction Hematopoietic stem cell transplantation-associated thrombotic microangiopathy
(TA-TMA) is a severe complication of transplant. TA-TMA is a multifactorial disease where …
(TA-TMA) is a severe complication of transplant. TA-TMA is a multifactorial disease where …
[HTML][HTML] Systematic review of signs and symptoms associated with hematopoietic stem cell transplantation-associated thrombotic microangiopathy
CE Dandoy, WH Tsong, K Sarikonda… - … and Cellular Therapy, 2023 - Elsevier
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-
TMA) is a serious complication of the transplantation process that has been consistently …
TMA) is a serious complication of the transplantation process that has been consistently …
Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort study
LP Yang, P Zhao, YJ Wu, HX Fu, Y He, XD Mo… - Bone Marrow …, 2022 - nature.com
The efficacy and outcome of therapeutic plasma exchange (TPE) for transplant-associated
thrombotic microangiopathy (TA-TMA) remain controversial. We therefore sought to evaluate …
thrombotic microangiopathy (TA-TMA) remain controversial. We therefore sought to evaluate …
Clinico-pathological correlations and outcomes of de novo glomerular diseases in patients after haematopoietic stem cell transplantation
DYH Yap, D Lie, T Lau, A Tang, G Chan… - Clinical Kidney …, 2023 - academic.oup.com
Background Various glomerular pathologies have been reported in patients who have
undergone haematopoietic stem cell transplantation (HSCT), but the data on clinico …
undergone haematopoietic stem cell transplantation (HSCT), but the data on clinico …
Onconephrology and thrombotic microangiopathy: looking beyond the horizon
P Gudsoorkar, A Abudayyeh, A Tchakarov… - Seminars in …, 2022 - Elsevier
Thrombotic microangiopathies (TMAs) represent a complex interaction of endothelial and
podocyte biology, nephron physiology, complement genetics, and oncologic therapies with …
podocyte biology, nephron physiology, complement genetics, and oncologic therapies with …